Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Müller · SciRah

Researcher profile · Semantic Scholar

L. Müller

Share profile

L. Müller — researcher profile on SciRah

h-index: 18
Works: 120
Citations: 1,876

Most-cited papers

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial.
U. Pelzer, B. Opitz, G. Deutschinoff, M. Stauch +11 more
2015Journal of Clinical Oncology257 citations
Semantic Scholar
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
M. Thomas, S. Ponce-Aix, A. Navarro, J. Riera-Knorrenschild +33 more
2018Annals of Oncology76 citations Open access
Semantic Scholar
A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type KRAS who have received first‐line systemic therapy
C. Eng, A. Bessudo, L. Hart, A. Severtsev +12 more
2016International Journal of Cancer62 citations Open access
Semantic Scholar
Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry
N. Marschner, M. Staehler, L. Müller, A. Nusch +4 more
2017Clinical Genitourinary Cancer54 citations Open access
Semantic Scholar
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase
M. Jawhar, N. Naumann, J. Schwaab, H. Baurmann +25 more
2017Annals of Hematology53 citations Open access
Semantic Scholar
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
N. Harbeck, S. Saupe, E. Jäger, Marcus Schmidt +16 more
2016Breast Cancer Research and Treatment41 citations Open access
Semantic Scholar
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group
M. Hoechstetter, R. Busch, B. Eichhorst, A. Bühler +25 more
2020Leukemia40 citations
Semantic Scholar
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study
N. Maass, N. Harbeck, C. Mundhenke, Christian A. Lerchenmüller +16 more
2013Journal of Cancer Research and Clinical Oncology37 citations Open access
Semantic Scholar
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts
C. Thomssen, D. Lüftner, M. Untch, R. Haidinger +20 more
2020Breast Care36 citations Open access
Semantic Scholar
SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11).
M. Retz, J. Bedke, Martin Boegemann, M. Grimm +14 more
2019European Journal of Cancer29 citations
Semantic Scholar
Abstract PD3-12: Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial
T. Fehm, V. Mueller, M. Banys-Paluchowski, P. Fasching +15 more
202126 citations
Semantic Scholar
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
U. Proetel, Nadine Pletsch, M. Lauseker, M. Müller +21 more
2014Annals of Hematology22 citations Open access
Semantic Scholar
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Christian Michel, A. Burchert, A. Hochhaus, S. Saussele +57 more
2018Haematologica21 citations Open access
Semantic Scholar
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry
M. Metzenmacher, F. Griesinger, H. Hummel, C. Elender +18 more
2022European Respiratory Journal20 citations Open access
Semantic Scholar
ABC3 Consensus: Assessment by a German Group of Experts
C. Thomssen, D. Augustin, J. Ettl, R. Haidinger +11 more
2016Breast Care15 citations Open access
Semantic Scholar
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS.
P. Opitz, S. Zimmermann, Anna M. Mc Laughlin, L. Müller +5 more
2022Journal of Pharmaceutical and Biomedical Analysis14 citations
Semantic Scholar
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial.
F. Honecker, N. Harbeck, C. Schnabel, U. Wedding +11 more
2017Journal of Geriatric Oncology14 citations
Semantic Scholar
Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
P. Goebell, L. Müller, A. Hübner, H. Harich +4 more
2018Urologic oncology13 citations Open access
Semantic Scholar
Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
R. Chekerov, P. Harter, S. Fuxius, L. Hanker +14 more
2017Gynecologic Oncology Research and Practice12 citations Open access
Semantic Scholar
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass).
V. Grünwald, P. Ivanyi, S. Zschäbitz, M. Wirth +21 more
2023European Urology11 citations Open access
Semantic Scholar
Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil
E. Schmulenson, Nigina Zimmermann, L. Müller, Stefanie Kapsa +2 more
2022Cancer Medicine10 citations Open access
Semantic Scholar
ABC4 Consensus: Assessment by a German Group of Experts
N. Harbeck, D. Lüftner, N. Marschner, M. Untch +9 more
2018Breast Care10 citations Open access
Semantic Scholar
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial.
K. Dorman, S. Boeck, K. Caca, Maximilian Reichert +16 more
2024The Lancet Gastroenterology and Hepatology9 citations
Semantic Scholar
ABC3 Consensus Commented from the Perspective of the German Guidelines
M. Untch, D. Augustin, J. Ettl, R. Haidinger +11 more
2016Geburtshilfe und Frauenheilkunde9 citations Open access
Semantic Scholar
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
A. Ballhausen, M. Karthaus, S. Fruehauf, U. Graeven +16 more
2023European Journal of Cancer8 citations Open access
Semantic Scholar
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
A. Welt, M. Wiesweg, S. Theurer, W. Abenhardt +10 more
2020Cancer Medicine8 citations Open access
Semantic Scholar
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study.
P. Goebell, L. Müller, H. Hurtz, M. Koska +2 more
2016Clinical Genitourinary Cancer8 citations
Semantic Scholar
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017
M. Untch, R. Würstlein, N. Marschner, D. Lüftner +9 more
2018Geburtshilfe und Frauenheilkunde7 citations Open access
Semantic Scholar
Ibrutinib in Early Stage CLL: Preliminary Safety Results of a Placebo-Controlled Phase III Study
P. Langerbeins, J. Bahlo, C. Rhein, P. Cramer +14 more
20157 citations
Semantic Scholar
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach
H. Schmalenberg, S. Al-Batran, C. Pauligk, T. Zander +13 more
2018Journal of Cancer Research and Clinical Oncology6 citations Open access
Semantic Scholar
Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma: Final Results of a National Multicenter Randomized Controlled Phase III Study
M. Kropff, M. Vogel, Andreas Kreter, R. Schlag +8 more
20146 citations
Semantic Scholar
Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial
A. Stahler, Meinolf Karthaus, S. Fruehauf, U. Graeven +16 more
2024EClinicalMedicine5 citations Open access
Semantic Scholar
ABC7 Consensus: Assessment by a German Group of Experts
N. Ditsch, M. Untch, P. Fasching, Steffi Busch +11 more
2024Breast Care5 citations Open access
Semantic Scholar
Discussion of ABC7 Consensus and German Recommendations
M. Untch, N. Ditsch, P. Fasching, Steffi Busch +11 more
2024Geburtshilfe und Frauenheilkunde5 citations Open access
Semantic Scholar
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC‐Registry
M. Staehler, P. Goebell, L. Müller, Till-Oliver Emde +4 more
2019International Journal of Cancer5 citations Open access
Semantic Scholar
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study.
P. Goebell, A. Münch, L. Müller, H. Hurtz +3 more
20145 citations
Semantic Scholar
Endpoint Surrogacy in Chronic Lymphocytic Leukemia: A Pooled Analysis of the German CLL Study Group
F. Simon, R. Ligtvoet, S. Robrecht, P. Cramer +29 more
2023Blood4 citations Open access
Semantic Scholar
Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).
D. Modest, M. Karthaus, Stefan Frühauf, U. Graeven +16 more
20214 citations
Semantic Scholar
Bendamustine Followed By Obinutuzumab and Idelalisib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BCG Trial of the German CLL Study Group (GCLLSG)
P. Cramer, J. von Tresckow, A. Fink, Gracia Braun +16 more
2020Blood4 citations Open access
Semantic Scholar
Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group
V. Goede, R. Busch, J. Bahlo, Viktoria Chataline +9 more
2016Leukemia and Lymphoma4 citations
Semantic Scholar
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial
T. Seufferlein, L. Lausser, Alexander Stein, Dirk Arnold +15 more
2024PLoS ONE3 citations Open access
Semantic Scholar
4. Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom (ABC4), Lissabon, 04.11.2017
M. Untch, R. Würstlein, N. Marschner, D. Lüftner +9 more
2018Senologie - Zeitschrift für Mammadiagnostik und -therapie3 citations
Semantic Scholar
Prognostic factors for overall survival of patients with advanced renal cell carcinoma - data from the German prospective RCC-Registry
P. J. Göbell, L. Müller, M. Stähler, Martin Müller +4 more
20173 citations
Semantic Scholar
Update on Female Cancer in Africa: The AORTIC Conference 2015, Morocco
C. Thomssen, D. Augustin, J. Ettl, R. Haidinger +24 more
2016Breast Care3 citations Open access
Semantic Scholar
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS ‐wild‐type metastatic colorectal cancer treated with first‐line panitumumab plus FOLFIRI/FOLFOX: Final results of the non‐interventional study VALIDATE
K. Potthoff, J. Uhlig, L. Jacobasch, L. Müller +16 more
2025International Journal of Cancer2 citations Open access
Semantic Scholar
Redefining early vs late progressive disease (PD) in chronic lymphocytic leukemia: A pooled analysis of fixed-duration therapies
F. Simon, R. Ligtvoet, M. Fürstenau, S. Robrecht +29 more
2025Blood2 citations
Semantic Scholar
Head‐to‐head comparison of TKI and CPI first‐line treatment strategies in advanced renal cell carcinoma—Real‐world data from the German research platform CARAT
P. Goebell, M. Bögemann, A. Nusch, Viktor Grünwald +11 more
2025International Journal of Cancer2 citations Open access
Semantic Scholar
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)
K. Heinrich, V. Heinemann, S. Stintzing, L. Müller +16 more
2024Oncology Research and Treatment2 citations Open access
Semantic Scholar
Exploring the molecular profile of localized colon cancer: insights from the AIO Colopredict Plus registry
Ira Ekmekciu, Doreen M. Zucha, J. Christmann, S. Wisser +13 more
2024Frontiers in Oncology2 citations Open access
Semantic Scholar
Predicting resistance to first-line FOLFOX plus bevacizumab in metastatic colorectal cancer: Final results of the multicenter, international PERMAD trial.
T. Seufferlein, T. Ettrich, A. Stein, D. Arnold +13 more
20212 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Marschner×13
Invite
N. Marschner — researcher profile on SciRah
N. Harbeck×9
Invite
N. Harbeck — researcher profile on SciRah
D. Lüftner×9
Invite
D. Lüftner — researcher profile on SciRah
R. Haidinger×9
Invite
R. Haidinger — researcher profile on SciRah

E. Ruckhäberle

×9

Invite

E. Ruckhäberle — researcher profile on SciRah

Invite

M. Untch — researcher profile on SciRah

Invite

D. Augustin — researcher profile on SciRah

Invite

J. Ettl — researcher profile on SciRah

Invite

C. Thomssen — researcher profile on SciRah

Invite

M. Jänicke — researcher profile on SciRah

Invite

V. Müller — researcher profile on SciRah

Invite

M. Koska — researcher profile on SciRah